What’s the science behind Botox injections for androgenetic alopecia?

It may seem unlikely that a toxin used in aesthetic medicine could help restore hair, but a small number of clinical studies have explored the idea. This article summarises what those published studies report, and what their limitations are. Botulinum toxin is not approved anywhere for hair loss, so any scalp injection for androgenetic alopecia is an off-label use.

First, how Botox is thought to work

Its active ingredient is botulinum toxin type A, which blocks the release of acetylcholine, a substance necessary for muscle contraction. This causes muscles to relax. On the face, that softens wrinkles; on the scalp, the hypothesis is that relaxation reduces pressure from the muscles on the scalp's blood vessels and improves local circulation. Better blood flow could in theory help hair follicles receive more oxygen and nutrients. This remains a hypothesis — none of the published hair studies measured scalp blood flow directly.

Androgenetic alopecia is a progressive condition characterised by miniaturisation of the hair follicle, usually attributed to the action of dihydrotestosterone (DHT), a hormone derived from testosterone. The proposal is that tense scalp muscles compress blood vessels and add to that process, and that relaxing them could help.

What the individual studies report

One of the earlier reports was a pilot study from India published in 2017 in the Journal of Cutaneous and Aesthetic Surgery. It involved ten men with androgenetic alopecia between grades II and IV on the Norwood-Hamilton scale, given scalp injections and followed for 24 weeks. Evaluation was done through clinical photographs and patient self-assessment. Eight of the ten participants reported a good or excellent improvement in hair density, and seven said they were satisfied with the results. The study had no control group and a very small sample, so it cannot show that the treatment caused the change.

Zhou and colleagues published a larger study in 2020 in BioMed Research International. Sixty-three patients with androgenetic alopecia were treated either with botulinum toxin type A injections alone or with the injections plus oral finasteride, a 5-alpha-reductase inhibitor that lowers DHT. Injections were repeated every three months, four times in total. The authors report that hair counts rose significantly from baseline in both groups, that the combination group did better than injections alone, and effective rates of 73.3% for injections alone and 84.8% for the combination. Reported side effects were mild, such as headache or local discomfort. The study had no placebo or untreated control group, which is the main limit on how much weight the result can carry.

A 2024 split-scalp randomised trial published in Dermatology and Therapy compared intramuscular and intradermal injection. Each participant's scalp was divided at the midline so that one side received intramuscular injections into the surrounding muscles and the other side intradermal injections into the balding area; 29 patients completed the study, with trichoscopic measurement of hair density and diameter at 12 weeks. Both approaches increased hair diameter, with no significant difference between them, while intramuscular injection significantly improved density more. Intradermal injection was more painful. One participant developed alopecia areata after injection — a reminder that immune reactions are possible and that this is not a risk-free procedure.

In 2025, a meta-analysis in Dermatologic Surgery (Cheng and colleagues) pooled eight studies and found a statistically significant increase in hair count with botulinum toxin compared with control (standardised mean difference 1.02; 95% CI 0.30–1.74). The authors describe the treatment as promising, while noting that most of the underlying work consists of small clinical studies.

An earlier systematic review, published in 2022 in Skin Appendage Disorders by English and Ruiz, is more explicit about the weaknesses. It included five clinical studies — four prospective cohorts and one randomised trial — running 24 to 60 weeks, with 165 male participants in total. Response rates ranged from 75% to 79.1%, and hair-count changes from intramuscular injection ranged from 18% to 20.9%. No serious adverse events were reported. The reviewers stress that no study included a control group or compared botulinum toxin against approved treatments, that participant numbers were small, and that study quality scores were relatively low, so the results should be read with caution. Large randomised trials are still needed, including in women, whom these studies did not enrol.

Proposed mechanisms

Beyond circulation, authors in this field have proposed that relaxing scalp muscles could reduce local levels of TGF-β1, a signalling protein linked to the suppression of hair growth, and that animal work points to increases in growth factors such as VEGF, which are associated with the anagen or active growth phase. A 2025 review in the journal Toxins suggests that effects on inflammation, blood flow and the local hormonal environment could explain why some patients respond. These mechanisms are proposals drawn from laboratory and animal work; the reviews themselves note that the absence of trials with direct measurements limits what can be concluded.

Safety

Across the published studies, reported side effects are described as mostly mild: injection-site pain, nausea and headache. One participant in the 2024 trial developed alopecia areata after injection. No serious or systemic adverse effects were reported in these studies, but they were small and short, so they were not designed to detect uncommon harms, and the long-term safety of repeated scalp injections for hair loss has not been established. Botulinum toxin products also carry a boxed warning about the distant spread of toxin effect.

User Experiences with Botox for Hair Loss

Botox, long known for its cosmetic uses, is discussed in the Tressless community as an off-label option for androgenetic alopecia (AGA). It is not a mainstream therapy, but a number of users have shared their experiences and opinions about it.

The studies above are what community members generally point to. A 2010 pilot study reported an 18% increase in hair count in men with AGA and a response rate around 75%, with no serious adverse events reported — but with no control group. Users also cite the proposal that botulinum toxin reduces TGF-β1 secretion. The community response has been cautiously optimistic. In a thread titled "Botox is as effective as Finasteride in treating hair loss", users debated a study framed that way; some suggested combining Botox with minoxidil and microneedling, while others were sceptical, citing the lack of large-scale clinical validation. No study has actually compared botulinum toxin head-to-head against finasteride, so the thread title overstates what the evidence shows.

Another user shared results in the post "Botox for Hair Loss", reporting reduced scalp itch and shedding after scalp injections, while noting it was too early to assess regrowth. In "anybody actually got botox on their scalp and had success?", members discussed the theoretical benefit of reducing scalp muscle tension. One commenter described tension in the galea aponeurotica — the connective tissue layer under the scalp — as possibly restricting blood flow. Other posts questioned practicality and availability. In "Has anyone found any US Doctors willing to do Botox injections for hair loss?", a user searched for providers and said they preferred Botox to finasteride because of concerns about hormonal side effects — a personal preference, not a comparison supported by trial data.

The post "The Effect of Intradermal Botox on Androgenetic Alopecia and Its Possible Mechanism" gained traction for its description of the proposed mechanism — blocking DHT-induced TGF-β1 secretion from dermal papilla cells. Several users were intrigued; many emphasised the experimental nature of the treatment and called for more clinical trials. Overall the community shows a mix of curiosity, anecdotal reports and caution. These are personal accounts, not evidence.

Where this leaves things

The use of botulinum toxin for androgenetic alopecia is an experimental, off-label treatment. It is not FDA-approved for this purpose. The treatments with regulatory approval for pattern hair loss are minoxidil and finasteride, which have far larger and better-controlled evidence behind them. The published botulinum toxin studies are small, mostly uncontrolled, and short; a pooled analysis reports a positive effect, and the reviewers of that literature say the same trials are too weak to settle the question. Larger studies with placebo groups, objective measurements and longer follow-up are needed.

Talk to a doctor or pharmacist before starting, stopping or combining any hair-loss treatment, including off-label botulinum toxin injections. Botulinum toxin is a prescription-only medicine and must be injected by a suitably trained clinician.

References

Pilot study in India (2017): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782443/

Zhou Y, et al. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia. Biomed Res Int. 2020;2020:1501893: https://pubmed.ncbi.nlm.nih.gov/32802833/

Li J, et al. Intradermal Injection in Balding Region Versus Intramuscular Injection in Surrounding Muscles: A Split-Scalp, Randomized Trial on BoNT for Androgenetic Alopecia. Dermatol Ther (Heidelb). 2024;14(6):1671–1682: https://link.springer.com/article/10.1007/s13555-024-01189-x

Cheng F, et al. Effects and Safety of Botulinum Toxin Injection in Treatment of Androgenetic Alopecia: A Meta-analysis and Systematic Review. Dermatol Surg. 2025: https://pubmed.ncbi.nlm.nih.gov/39840856/

English RS Jr, Ruiz S. Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review. Skin Appendage Disord. 2022;8(2):93–100: https://pubmed.ncbi.nlm.nih.gov/35415183/

Toxins review (2025): https://www.mdpi.com/2072-6651/17/4/163

https://reddit.com/r/tressless/comments/k1v5uv/botox_is_as_effective_as_finasteride_in_treating/

https://reddit.com/r/tressless/comments/dkomk4/botox_for_hair_loss/

https://reddit.com/r/tressless/comments/oejfmt/anybody_actually_got_botox_on_their_scalp_and_had/

https://reddit.com/r/tressless/comments/m7u7hx/has_anyone_found_any_us_doctors_willing_to_do/

https://reddit.com/r/tressless/comments/gcfolc/the_effect_of_intradermal_botox_on_androgenetic/

https://reddit.com/r/tressless/comments/f3oyo3/using_botox_more_effective_than_finasteride_and/

https://reddit.com/r/tressless/comments/127xij3/what_about_botox_injections_on_the_scalp/